Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 | MMWR - Centers for Disease Control and Prevention (.gov)

Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 | MMWR - Centers for Disease Control and Prevention (.gov)
This report describes the increase in infection-induced antibodies against COVID-19 during Omicron predominance.
On April 26, 2022, this report was posted online as an MMWR Early Release.In December 2021, the B.1.1.529 (Omicron) variant of SARS-CoV-2, the virus that causes COVID-19, became predominant in the Un… [+7124 chars] Read More



Related Stories

See All